1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric CancerNeoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasmActive, not recruitingPhase 2 / Phase 32026-01-23NCT04208347